School of Medicine
Showing 31-40 of 42 Results
-
Andrew Philip Martella
Clinical Associate Professor, Radiation Oncology - Radiation Therapy
BioDr. Martella is a fellowship-trained radiation oncologist and a clinical assistant professor of radiation oncology at Stanford University School of Medicine.
His clinical interests include gynecologic, breast, thoracic, gastrointestinal, genitourinary, and central nervous system cancers. His experience encompasses the full range of radiotherapy techniques, including intensity modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT), stereotactic body radiotherapy (SBRT), CyberKnife radiosurgery, eye plaque brachytherapy, and prostate and gynecologic high dose rate (HDR) brachytherapy.
Dr. Martella is dedicated to improving the quality of care and the patient experience. He deeply values a close relationship with his patients and their loved ones. He feels that each patient experiences healthcare in a unique and individual way. By recognizing and responding to those individual needs Dr. Martella provides a truly patient-centered experience. He has helped conduct research into noninvasive deep brain stimulation and chromosomal topography,and published on the topic of treating rectal cancer without radiation. He also was the primary contributing author of chapters in the book First Aid for the United States Medical Licensing Examination.
Dr. Martella has delivered presentations at the Annual Meeting of the American Society for Therapeutic Radiology and Oncology. Topics include chemotherapy and radiotherapy in endometrial cancer.
Among the honors for scholarship that Dr. Martella has received, he graduated first in his class at Duke University School of Medicine. He was also elected during medical school into Alpha Omega Alpha Honor Medical Society.
Dr. Martella’s community service has included a position on the board of directors of Camp Good Days and Special Times, a nonprofit organization that provides services for children who have cancer, have a parent or sibling with cancer, or have lost a parent or sibling to the disease. He has served on several leadership roles and has a deep dedication to furthering diversity and inclusion throughout the healthcare system. -
Everett J. Moding, MD, PhD
Assistant Professor of Radiation Oncology (Radiation Therapy)
Current Research and Scholarly InterestsMy laboratory performs translational research using analysis of human samples to identify critical mediators of treatment resistance that can be validated in preclinical models and targeted to enhance the efficacy of cancer therapy.
-
Prithvi Mruthyunjaya, MD, MHS
Alan Adler Professor of Ophthalmology and Professor, by courtesy, of Radiation Oncology
Current Research and Scholarly InterestsDr Mruthyunjaya has maintained a broad research interest with publications in both ocular oncology and retinal diseases.
His focus is on multi-modal imaging of ocular tumors and understanding imaging clues that may predict vision loss after ocular radiation therapy. He coordinates multi-center research on the role of genetic testing and outcomes of treatments of ocular melanoma.
In the field of retinal diseases, his interests are in intra-operative imaging to enhance surgical accuracy. -
Yushen Qian, MD
Clinical Associate Professor, Radiation Oncology - Radiation Therapy
BioDr. Qian is a board-certified radiation oncologist and a Clinical Associate Professor in the Stanford University School of Medicine, Department of Radiation Oncology.
In his clinical practice, he sub-specializes in genitourinary (including prostate and bladder cancer) and Head and Neck malignancies, but also treats a broad spectrum of other disease subsites including lung/thoracic, gastrointestinal, brain, lymphoma, and breast tumors. For each patient, he develops a comprehensive, individualized, and compassionate care plan customized to individual needs. His goal is to deliver the most effective cancer treatment to help patients enjoy the best possible health and quality of life.
In addition to his clinical practice, Dr. Qian serves as the Medical Director of Radiation Oncology at Stanford South Bay Cancer Center. He also serves as the Radiation Oncology Network Director of Clinical Research and has spearheaded opening of multiple NRG Oncology clinical trials at Stanford South Bay Cancer Center.
Dr. Qian is also actively involved in the Stanford Radiation Oncology residency program. He created and oversees a monthly mentorship roundtable series to assist residents with multiple aspects of their clinical training and career progression.
Outside of work, Dr. Qian enjoys spending time with his family and exploring the great outdoors of Northern California. -
Elham Rahimy, MD
Clinical Assistant Professor, Radiation Oncology - Radiation Therapy
BioDr. Rahimy is a radiation oncologist who treats patients with brain, spine, gastrointestinal, and metastatic tumors. She received her medical training at Yale, followed by residency at Stanford. She is a Clinical Assistant Professor with the Stanford Department of Radiation Oncology.
Dr. Rahimy's technical expertise includes CyberKnife Radiosurgery and MRI-guided adaptive planning. She is also actively involved in radiation oncology research and clinical trials. Her interests include improving patient and resident education, and enhancing patient quality of life and survivorship. She leads quality initiatives as a Quality Physician Improvement Leader, and serves as the Medical Student Clerkship Director. -
Yuan James Rao, MD
Associate Professor of Radiation Oncology (Radiation Therapy)
BioDr. Yuan James Rao is an Associate Professor of Radiation Oncology, and Co-Director of Proton Therapy at Stanford University. In 2026, Dr. Rao co-led the team at Stanford that treated the world’s first pediatric and adult patients with ultra-compact upright proton therapy. Dr. Rao’s professional goal is to develop the world’s most advanced proton therapy program at Stanford University.
Proton therapy is a remarkable form of radiation treatment that uses heavy charged particles (protons) accelerated to approximately two-thirds the speed of light. The unique physics of protons allows the radiation to stop within a defined distance in the body, whereas standard x-ray therapy continues to deposit radiation after treating the tumor (known as “exit dose”). By reducing exit dose, protons may reduce normal tissue exposure to radiation, which is particularly beneficial for children and young adults with cancer, and patients requiring a second course of radiation. Dr. Rao currently coordinates the Stanford Radiation Oncology Department’s clinical, research, and education efforts related to proton therapy.
Dr. Rao’s clinical practice focuses on the care of patients with Head and Neck cancer, and Thoracic cancers. His goal is to provide the highest quality care to his patients, using the most appropriate technology. This may include proton therapy but also potentially other techniques such as intensity modulated radiation therapy (IMRT), stereotactic body radiation (SBRT), MR-guided radiotherapy, 3D conformal radiotherapy, or other technologies. Nearly all radiation technologies are available at Stanford University, and thus Dr. Rao and his Radiation Oncology colleagues are well positioned to choose the best treatment for every patient.
Dr. Rao trained at the prestigious Mallinckrodt Institute of Radiology at Washington University in St. Louis, and during residency was among the first physicians in the world to use the Mevion S250 proton therapy device and the ViewRay MRI-guided radiotherapy device. Dr. Rao has traveled to UCSF, MD Anderson, Johns Hopkins University, University of Pennsylvania, Medical University of Vienna, and University Medical Center Utrecht to learn about various advanced radiotherapy techniques including MR-guided radiotherapy, brachytherapy, and proton therapy.
Prior to his role at Stanford, Dr. Rao was a physician at George Washington University in Washington, DC and held the positions of Associate Professor of Radiation Oncology and Biomedical Engineering (by courtesy), and Assistant Professor of Neurosurgery (by courtesy). He was also the founding Director of Brachytherapy, and implemented programs for gyn, head and neck, prostate, and skin radiation implants using high dose rate (HDR) techniques. He was honored as a Washingtonian Top Doctor for each of the years that he practiced in DC, and Dr. Rao has treated members of Congress with radiotherapy (public information).
Dr. Rao is a prolific researcher with more than 50 peer-reviewed publications. He is an expert in proton therapy, head and neck cancer, thorax cancers, gyn cancers, GU cancers, brachytherapy, artificial intelligence, machine learning, image analysis and large database "big data." He is co-author of the ‘Endometrial Cancer’ chapter of the 8th edition of Perez and Brady’s Principles and Practice of Radiation Oncology, the world’s most widely used reference textbook in the field. He regularly gives invited talks nationally and internationally. Dr. Rao has been grant funded by the American Cancer Society.
Dr. Rao is a respected educator and mentor, and has taught numerous engineering/physics students, medical students and residents; many of whom have gone on to become successful physicists, scientists, entrepreneurs, and physicians. -
Jason B. Ross, MD, PhD
Assistant Professor of Radiation Oncology (Radiation Therapy)
Current Research and Scholarly InterestsMy laboratory studies studying normal, dysfunctional, and malignant stem cells in the context of aging, cancer, and cancer therapies.
-
Scott G. Soltys, MD
Professor of Radiation Oncology (Radiation Therapy) and, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsMy clinical and research interests focus on the development of new radiation techniques involving stereotactic radiosurgery and radiotherapy for the treatment of malignant and benign tumors of the brain and spine, as well as functional disorders such as trigeminal neuralgia.
